"We said 2026 would be a year of accelerated growth and impact for Johnson & Johnson. And with our strong Q1 performance, including our beat on consensus and raised guidance, you can see we are ...

Johnson & Johnson is facing lawsuits, patent cliffs, and disruptive drug pricing negotiations. Despite that, the company's revenue continues to grow and should top $100 billion this year. The ...

Johnson & Johnson grew out of an 1876 lecture by Dr. Joseph Lister on the promising results seen in his new procedure, sterile surgery. Three brothers started Johnson & Johnson, finding a factory to ...